Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04405583 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

Study acronym: AFR Registry
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 6 of 36 sitesv10
  2. Study completion pushed from Oct 2027 to Jun 2031v9
  3. Primary completion date: Jun 30, 2025 to Jun 30, 2027
    • Study sites: 14 to 36
    v8
  4. Enrollment target: 100 to 150v7 Show 5 more changesShow less
    • Primary endpoint revised
    • Primary completion date: Oct 2025 to Jun 30, 2025
    • Eligibility criteria expanded, about 467 words
    • Secondary endpoints: 4 to 13
    • Study description expanded, about 67 words
  5. Study sites: 13 to 14v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 12 to 13v5
  2. Study sites: 5 to 12
    • Study description expanded, about 55 words
    v4
  3. Primary completion date: Oct 2023 to Oct 2025
    • Study sites: 1 to 5
    • Study completion date: Oct 2025 to Oct 2027
    v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Aug 2023 to Oct 2023
    • Study completion date: Aug 2025 to Oct 2025
    • Start date changed from estimate of Aug 2020 to Oct 28, 2020
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to monitor the safety and efficacy of Occlutech AFR device in patients with Heart Failure.
Trial Details
NCT Number NCT04405583
Lead Sponsor Occlutech International AB
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov